
Leukemia & Lymphoma Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.
Featured
In the third part of this roundtable, Steven Horwitz, MD; Alison Moskowitz, MD; and Barbara Pro, MD, discuss notable advancements in the standard treatment of T-cell lymphoma.
View MoreIn the second part of this roundtable, Steven Horwitz, MD; Alison Moskowitz, MD; and Barbara Pro, MD, discuss the background, findings, and importance of the ECHELON-2 clinical trial.
View MoreIn the first part of this roundtable, Steven Horwitz, MD; Alison Moskowitz, MD; and Barbara Pro, MD, discuss the challenges of treating patients with T-cell lymphoma.
View MorePaolo Caimi, MD, discusses findings from a study examining the use of prophylactic tocilizumab prior to anti-CD19 CAR-T therapy for relapsed/refractory lymphoma.
View MoreDr Bussel shares insight on hot topics, highlights, and key takeaways from this year's virtual event.
View MoreDr Percival discusses the provision of care to patients with AML during the COVID-19 pandemic.
View MoreOn this episode of Blood Bytes, John Leonard, MD, and Richard Furman, MD, discuss BTK inhibitors for the treatment of CLL and lymphomas.
View MoreMary-Elizabeth Percival, MD, outlines considerations for treating patients with hematologic malignancies during the COVID-19 pandemic.
View MoreMehdi Hamadani, MD, discusses the impact the global pandemic has had on bone marrow and stem cell transplantation for patients with blood cancers.
View More